Concepedia

Nancy Agrawal

NA

31

Publications

1.4K

Citations

21

H-Index

2001

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pharmaceutical Product Development (United States)

Rutgers Cancer Institute

KU Leuven

Nancy Agrawal is an author at United States Military Academy specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2001–2021

31

Publications

31

A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer

Eric H. Rubin, Nancy Agrawal, Evan Friedman et al. · Clinical Cancer Research · 2006 · 113 citations · Full text

Characterization of Etoricoxib, a Novel, Selective COX‐2 Inhibitor

Aimée Dallob, Christopher J. Hawkey, Howard Greenberg et al. · The Journal of Clinical Pharmacology · 2003 · 91 citations

Etoricoxib in acute pain associated with dental surgery: A randomized, double-blind, placebo- and active comparator-controlled dose-ranging study

Kerstin Malmström, Aditi Sapre, Heather Couglin et al. · Clinical Therapeutics · 2004 · 87 citations

, , +11

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA<sub>A</sub>α<sub>2,3</sub>subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers

Sanne Lysbet de Haas, Saco J. de Visser, J. P. Van Der Post et al. · Journal of Psychopharmacology · 2006 · 85 citations

Absorption, Metabolism, and Excretion of Etoricoxib, a Potent and Selective Cyclooxygenase-2 Inhibitor, in Healthy Male Volunteers

A. David Rodrigues, Rita A. Halpin, Leslie A. Geer et al. · Drug Metabolism and Disposition · 2003 · 84 citations

Rows per page

1–5 of 31